mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Mfold web server for nucleic acid folding and hybridization prediction

Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129

Tolerance, Danger and the Extended Family

Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 5,107

Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information

Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604

Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964

Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,929

IRF Family of Transcription Factors as Regulators of Host Defense

Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658

Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4

Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378

Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo

den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway

Basu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000) · International Immunology · doi:10.1093/intimm/12.11.1539 · Cited by 1,318

Immunogenic cell death and DAMPs in cancer therapy

Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223

Sterile inflammation: sensing and reacting to damage

Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930

Astrocytes are active players in cerebral innate immunity

Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304

Mechanisms of Age-Related Macular Degeneration

Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,062

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C. J., Dunbar, P. R., Wadley, R. B., Jeet, V., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092140 · Cited by 1,019

DAMPening Inflammation by Modulating TLR Signalling

Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 1,008

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

Barrat, F. J., Meeker, T., Gregorio, J. D., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 932

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909

Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury

Gaudet, A. D., Popovich, P. G., & Ramer, M. S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-110 · Cited by 903

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

Semeraro, F., Ammollo, C. T., Morrissey, J. H., Dale, G. L., Friese, P., Esmon, N. L., & Esmon, C. T. (2011) · Blood · doi:10.1182/blood-2011-03-343061 · Cited by 870

The role of oxidative stress during inflammatory processes

Lugrin, J., Rosenblatt‐Velin, N., Parapanov, R., & Liaudet, L. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 766

TLR signaling tailors innate immune responses in human microglia and astrocytes

Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734

The immunology of acute stroke

Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. C. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 712

Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response

Festjens, N., Vanden Berghe, T., & Vandenabeele, P. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.06.014 · Cited by 710

Endogenous ligands of Toll-like receptors

Tsan, M., & Gao, B. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304127 · Cited by 690

Immune activation in brain aging and neurodegeneration: too much or too little?

Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 696

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses

Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642

Developing mRNA-vaccine technologies

Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K.-J. (2012) · RNA Biology · doi:10.4161/rna.22269 · Cited by 622

Pathogenic mechanisms following ischemic stroke

Khoshnam, S. E., Winlow, W., Farzaneh, M., Farbood, Y., & Moghaddam, H. F. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2938-1 · Cited by 636

Macrophage activation by endogenous danger signals

Zhang, X., & Mosser, D. (2007) · The Journal of Pathology · doi:10.1002/path.2284 · Cited by 629

Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain

Choe, J., Kelker, M. S., & Wilson, I. A. (2005) · Science · doi:10.1126/science.1115253 · Cited by 620

The tangled history of mRNA vaccines

Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-02483-w · Cited by 581

Endogenous toll‐like receptor ligands and their biological significance

Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 555

Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes

Uccellini, M. B., Broughton, C., Mackay, F., Akira, S., Marshak‐Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 528

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus

Christensen, S. R., Kashgarian, M. J., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 521

Self-assembled mRNA vaccines

Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514

Inflammation and fibrosis

Mack, M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 535

Toll-like receptor signaling in neural plasticity and disease

Okun, E., Griffioen, K. J. S., & Mattson, M. P. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.02.005 · Cited by 529

The dawn of mRNA vaccines: the COVID-19 case

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504

The Pathogenesis of Lupus Nephritis

Lech, M., & Anders, H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010026 · Cited by 502

Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation

Garg, A. D., Nowis, D., Gołąb, J., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.003 · Cited by 517

Molecular characteristics of immunogenic cancer cell death

Tesnière, A., Panaretakis, T., Kepp, O., Apétoh, L., Ghiringhelli, F., Zitvogel, L., & Kroemer, G. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402269 · Cited by 509

Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential

Hanke, M. L., & Kielian, T. (2011) · Clinical Science · doi:10.1042/cs20110164 · Cited by 498

Pattern recognition receptors and central nervous system repair

Kigerl, K. A., de Rivero Vaccari, J. P., Dietrich, W. D., Popovich, P. G., & Keane, R. W. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.001 · Cited by 490

Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines

Nance, K. D., & Meier, J. L. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00197 · Cited by 466

Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics

Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 493

Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 3

Karikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events

Cavassani, K. A., Ishii, M., Wen, H., Schaller, M. A., Lincoln, P., Lukacs, N. W., Hogaboam, C. M., & Kunkel, S. L. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081370 · Cited by 447

Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses

Garg, A. D., & Agostinis, P. (2017) · Immunological Reviews · doi:10.1111/imr.12574 · Cited by 451

RIG-I and Other RNA Sensors in Antiviral Immunity

Chow, K. T., Gale, M., & Loo, Y. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053309 · Cited by 432

Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal Localization

Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 422

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose

Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414

Many stimuli pull the necrotic trigger, an overview

Vanlangenakker, N., Berghe, T. V., & Vandenabeele, P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.164 · Cited by 418

Toll‐like receptors, endogenous ligands, and systemic autoimmune disease

Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. A., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 384

The molecular structure of the Toll-like receptor 3 ligand-binding domain

Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Segal, D. M., & Davies, D. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505077102 · Cited by 387

TLR signaling by tumor and immune cells: a double-edged sword

Huang, B., Zhao, J., Unkeless, J. C., Feng, Z., & Xiong, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210904 · Cited by 377

RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll‐like receptor 3

Brentano, F., Schorr, O., Gay, R. E., Gay, S., & Kyburz, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21273 · Cited by 377

Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects

Kon, E., Ad‐El, N., Hazan‐Halevy, I., Stotsky‐Oterin, L., & Peer, D. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00811-9 · Cited by 393

Microglia: Agents of the CNS Pro-Inflammatory Response

Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365

Toll‐like receptors in central nervous system glial inflammation and homeostasis

Kielian, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20767 · Cited by 373

Activation of the mammalian immune system by siRNAs

Marques, J. T., & Williams, B. R. G. (2005) · Nature Biotechnology · doi:10.1038/nbt1161 · Cited by 362

Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr586 · Cited by 356

A comprehensive map of the toll‐like receptor signaling network

Oda, K., & Kitano, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100057 · Cited by 362

NKG2D function protects the host from tumor initiation

Smyth, M. J., Swann, J. B., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 344

Three decades of messenger RNA vaccine development

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100766 · Cited by 342

Toll‐like receptor (TLR) expression and TLR‐mediated cytokine/chemokine production by human uterine epithelial cells

Schaefer, T. M., Desouza, K., Fahey, J. V., Beagley, K. W., & Wira, C. R. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01898.x · Cited by 341

Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

Vercammen, E., Staal, J., & Beyaert, R. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-07 · Cited by 329

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

Sato, Y., Goto, Y., Narita, N., & Hoon, D. S. �. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0022-y · Cited by 322

Clearance of apoptotic and necrotic cells and its immunological consequences

Krysko, D. V., D’Herde, K., & Vandenabeele, P. (2006) · Apoptosis · doi:10.1007/s10495-006-9527-8 · Cited by 316

A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity

Kim, D., Kim, M. A., Cho, I., Kim, M. S., Lee, S., Jo, E., Choi, S., Park, K., Kim, J. S., Akira, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607277200 · Cited by 315

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

Kreiter, S., Selmi, A., Diken, M., Koslowski, M., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0699 · Cited by 309

EMERGING PARADIGM

Mollen, K. P., Anand, R., Tsung, A., Prince, J. M., Levy, R. M., & Billiar, T. R. (2006) · Shock · doi:10.1097/01.shk.0000228797.41044.08 · Cited by 307

Emerging role of Toll-like receptors in the control of pain and itch

Liu, T., Gao, Y., & Ji, R. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1219-5 · Cited by 312

The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases

Nisini, R., Poerio, N., Mariotti, S., Santis, F. D., & Fraziano, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00155 · Cited by 308

Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators

Bsibsi, M., Persoon-Deen, C., Verwer, R. W. H., Meeuwsen, S., Ravid, R., & van Noort, J. M. (2006) · Glia · doi:10.1002/glia.20328 · Cited by 301

DAMPs as mediators of sterile inflammation in aging-related pathologies

Feldman, N., Rotter-Maskowitz, A., & Okun, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.003 · Cited by 283

Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases

Li, L., Acioglu, C., Heary, R. F., & Elkabes, S. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.007 · Cited by 283

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282

Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis

Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi‐Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278

Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung

Opitz, B., van Laak, V., Eitel, J., & Suttorp, N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1427so · Cited by 287

The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines

Morais, P., Adachi, H., & Yu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.789427 · Cited by 281

Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis

Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.014 · Cited by 272

Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression

Rudd, B. D., Burstein, E., Duckett, C. S., Li, X., & Lukacs, N. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3350-3357.2005 · Cited by 277

Principles for designing an optimal mRNA lipid nanoparticle vaccine

Kon, E., Elia, U., & Peer, D. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.09.016 · Cited by 269

Innate Immunity in the Human Female Reproductive Tract: Antiviral Response of Uterine Epithelial Cells to the TLR3 Agonist Poly(I:C)

Schaefer, T. M., Fahey, J. V., Wright, J. A., & Wira, C. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.992 · Cited by 265

Challenges in developing personalized neoantigen cancer vaccines

Katsikis, P. D., Ishii, K. J., & Schliehe, C. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00937-y · Cited by 285

Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance

Karikó, K., Weissman, D., & Welsh, F. A. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000145666.68576.71 · Cited by 258

Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH

de Bouteiller, O., Merck, E., Hasan, U. A., Hubac, S., Benguigui, B., Trinchieri, G., Bates, E. E. M., & Caux, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507163200 · Cited by 220

Transcriptional signaling by double-stranded RNA: role of TLR3

Sen, G. C., & Sarkar, S. N. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 260

Preferential expression and function of Toll-like receptor 3 in human astrocytes

Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., & Meinl, E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.009 · Cited by 256

Characterization of Toll-like receptors in the female reproductive tract in humans

Fazeli, A., Bruce, C., & Anumba, D. O. C. (2005) · Human Reproduction · doi:10.1093/humrep/deh775 · Cited by 246

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Wang, J., Ding, Y., Chong, K. C., Cui, M., Cao, Z., Tang, C., Tian, Z., Hu, Y., Zhao, Y., & Jiang, S. (2024) · Vaccines · doi:10.3390/vaccines12101148 · Cited by 270

Immunogenic cell death

Garg, A. D., Dudek-Perić, A. M., Romano, E., & Agostinis, P. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150061pa · Cited by 250

Inflammation and immune surveillance in cancer

Chow, M. T., Möller, A., & Smyth, M. J. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.004 · Cited by 253

The role of Toll-like receptors in the host response to viruses

Bowie, A., & Haga, I. R. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.11.007 · Cited by 249

ROLE OF TOLL-LIKE RECEPTORS IN THE DEVELOPMENT OF SEPSIS

Tsujimoto, H., Ono, S., Efron, P. A., Scumpia, P. O., Moldawer, L. L., & Mochizuki, H. (2008) · Shock · doi:10.1097/shk.0b013e318157ee55 · Cited by 243

Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals

Cameron, J. S., Alexopoulou, L., Sloane, J. A., DiBernardo, A., Ma, Y., Kosaras, B., Flavell, R. A., Strittmatter, S. M., Volpe, J. J., Sidman, R. L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4290-06.2007 · Cited by 236

mRNA as gene therapeutic: How to control protein expression

Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232

Strategies to reduce the risks of mRNA drug and vaccine toxicity

Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 242

Danger signalling during cancer cell death: origins, plasticity and regulation

Garg, A. D., Martin, S., Gołąb, J., & Agostinis, P. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.48 · Cited by 232

Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils

Cassatella, M. A., Mosna, F., Micheletti, A., Lisi, V., Tamassia, N., Cont, C., Calzetti, F., Pelletier, M., Pizzolo, G., & Krampera, M. (2011) · Stem Cells · doi:10.1002/stem.651 · Cited by 223

Mammalian Toll-like receptors: to immunity and beyond

Hopkins, P. A., & Sriskandan, S. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02801.x · Cited by 233

mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo

Rybakova, Y., Kowalski, P. S., Huang, Y., Gonzalez, J. T., Heartlein, M. W., DeRosa, F., Delcassian, D., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.012 · Cited by 218

siRNA and isRNA: two edges of one sword

Schlee, M., Hornung, V., & Hartmann, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.001 · Cited by 217

Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells

Ioannidis, I., Ye, F., McNally, B. A., Willette, M., & Flaño, E. (2013) · Journal of Virology · doi:10.1128/jvi.01956-12 · Cited by 221

Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword

Dajon, M., Iribarren, K., & Cremer, I. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.06.009 · Cited by 215

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Lint, S. V., Goyvaerts, C., Maenhout, S. K., Goethals, L., Disy, A., Benteyn, D., Pen, J. J., Bonehill, A., Heirman, C., Breckpot, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2957 · Cited by 210

Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3

Amarante, M. K., Oda, J. M. M., Reiche, E. M. V., Morimoto, H. K., Aoki, M. N., & Watanabe, M. A. E. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.303 · Cited by 7

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129

Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses

Tatematsu, M., Seya, T., & Matsumoto, M. (2014) · Biochemical Journal · doi:10.1042/bj20131492 · Cited by 77

Transcriptional signaling by double-stranded RNA: role of TLR3

Sen, G. C., & Sarkar, S. N. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 260

Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

Vercammen, E., Staal, J., & Beyaert, R. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-07 · Cited by 329